Baudax Bio, Inc. BXRXQ
—
0.00
0.00
NaN
as of 25 Sep
- Market cap
- —
- P/E
- 0.0×
Follow BXRXQ
Growth Flags
show if company had growth for consecutive years
| Sep '23 | Jun '23 | Mar '23 | Dec '22 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | — |
+8 more quarters Free account |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
0.02 | 0.07 | 0.31 | 0.25 | |
Current Ratio |
0.07 | 0.09 | 0.33 | 0.30 | |
Net Debt/EBITDA |
(2.96) | (0.63) | (0.77) | (0.05) | |
Debt/Assets |
25.40% | 27.50% | 105.21% | 70.96% | |
Debt/Equity |
(0.51) | (0.55) | (1.02) | (0.29) | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.23 | 0.46 | (0.35) | 1.59 | |
Capex/Depreciation |
(0.16) | 0.00 | 0.00 | (0.01) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.62 | 0.60 | 0.30 | 0.21 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.30) | (0.69) | (1.70) | (44.27) | |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.06) | |
Free Cash Flow per Share |
(0.30) | (0.69) | (1.70) | (44.33) | |
Cash per Share |
0.05 | 0.29 | 1.64 | 15.84 | |
Shareholders Equity per Share |
(1.28) | (2.19) | (3.15) | (73.02) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(1.28) | (2.19) | (3.15) | (73.02) | |
Free Cash Flow |
(2.39) | (3.37) | (3.94) | (14.72) | |
Working Capital |
(17.71) | (18.60) | (8.26) | (15.11) | |
Capital Expenditures |
(0.02) | — | — | (0.02) | |
Net Current Asset Value |
(29.48) | (30.13) | (10.27) | (27.93) | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | — | — | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Payables |
5.72 | 4.45 | 3.56 | 2.33 | |
Average Assets |
19.05 | 31.08 | 27.94 | 31.65 | |
Average Common Equity |
(14.89) | (3.22) | 1.22 | (5.51) |
Columns are period end dates